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 A 1-year-old female domestic shorthair cat ingested about 1.6 mg/kg body weight 
of baclofen. Hyperexcitability, disorientation and ataxia followed by severe central 
nervous system depression were noted. Hypothermia, bradycardia and tachypnea 
were developed. Therapy with an intravenous emulsion of 20% soybean oil in water 
was started because conventional therapies did not control clinical signs. A bolus of 
2 ml/kg in 15 minutes following by constant rate infusion of 0.05 ml/kg/min for 4 
hours was administered. Within one hour of starting the lipid administration, the 
cats’ breathing, heart rate and patient mental state improved. Rectal temperature 
normalized. At the end of lipid infusion heart and respiratory rate were in the 
reference range as well as neurological signs resolved. The cat was discharged after 
5 days of hospitalization. No recurrence of clinical signs was reported. 
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Baclofen is a centrally acting skeletal muscle 
relaxant. It mimics y-aminobutyric acid within the spinal 
cord and works by depressing monosynaptic and 
polysynaptic afferent reflex activity. Baclofen is used in 
people with multiple sclerosis, cerebral palsy and spinal 
cord disorders to treat muscle spasticity and pain 
(Khorzad et al., 2012; Edwards et al., 2014). Several 
cases of baclofen intoxication have been reported in dogs 
due to ingesting their owners’ medication (Robben and 
Dijkman, 2017) but few cases of cats have been reported 
(Edwards et al., 2014). 
Clinical signs of poisoning include salivation, 
weakness, mydriasis, miosis, nystagmus, blindness, 
dysphoria, agitation, hyperactivity, tremors and ataxia. 
Gastrointestinal, cardiovascular, respiratory and 
urogenital clinical signs are also described. Coma, 
seizures, hypothermia and respiratory arrest may occur 
(Khorzad et al., 2012; Edwards et al., 2014). There is no 
specific antidote, but experimental studies and case 
reports supported the use of intravenous lipid emulsion 
(ILE) in the management of intoxication from lipophilic 
drugs (Fernandez et al., 2011). Treatment of baclofen 
toxicosis through ILE has been described in six dogs and 
one cat (Khorzad et al., 2012; Bates et al., 2013; Edwards 
et al., 2014).  
The present report describes the second case of 
baclofen toxicosis in a cat that was successfully treated with 
ILE at lower dose as an adjunct to supportive therapy.  
History and clinical examination: A 1-year-old spayed 
female domestic shorthair weighing 3 kg was presented at 
the Small Animal Emergency Service because of severe 
hyperexcitability, disorientation and ataxia. The owner 
reported that the cat accidentally ingested a quarter of a 20 
mg baclofen tablet. The cat vomited several times before 
presentation to the hospital.  
On general physical examination, rectal temperature 
was 38.4°C and capillary refill time was <2 sec.  
Respiratory rate was 32 breaths/min and mucous 
membranes were pink and moist. The cat showed 
bradycardia (130 beats/min) with normal sinus rhythm. 
Pulse quality was normal and systolic blood pressure 
(Doppler method) was 120 mmHg. 
Neurological exam revealed disoriented mentation 
and marked hyperexcitability. General proprioceptive 
ataxia was noticed at gait examination. No proprioceptive 
or postural reaction deficits were found. Menace response 
was absent bilaterally and bilateral mydriasis was 
observed. Pupillary light reflex was present. The 
remainder of the neurological examination was 
unremarkable. Blood samples were taken for routine 
laboratory evaluations. Complete blood count (CBC) did 
not show any abnormality. Biochemical profile was 
normal with the exception of increased alanine 
aminotransferase (ALT=520U/L; reference interval, 12-
130U/L) and aspartate aminotransferase (AST=338U/L; 
reference interval, 0-48U/L) activities. Venous blood gas 
analysis revealed mild hypokalemia (K=3mmol/L; 
reference interval, 3.9-5.5mmol/L).  
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Diagnosis and treatment: On the basis of medical 
history and clinical signs, diagnosis of acute baclofen 
toxicosis was made. The cat was admitted to the Intensive 
Care Unit. An intravenous catheter was placed in the right 
cephalic vein and intravenously Ringer lactate solution at 
a rate of 5 ml/kg/h was supplemented with potassium 
chloride (28 mEq/L) for maintaining hydration, restoring 
normal potassium level and promoting drug elimination. 
Omeprazole (1 mg/kg, IV, q24h) and ondansetron (0.2 
mg/kg, IV, q8h) were added for treatment of vomiting. 
Approximately, 2 hours following hospital admission, the 
cat was severely depressed. Mental state progressively 
worsened to coma. Bilateral miosis and bilaterally absent 
pupillary light reflex were noticed with hypothermia 
(rectal temperature, 36.7°C). The cat was tachypneic (40 
breaths/min) with superficial breath. However, oxygen 
saturation measured by pulse oximetry was >95%. 
Bradycardia worsened (120 beats/min) but pulse quality 
and systolic blood pressure remained normal. The cat was 
warmed with an external heating device. Therapy with an 
intravenous emulsion of 20% soybean oil in water was 
started (Intralipid; Fresenius Kabi Italia). A bolus of 2 
ml/kg in 15 minutes followed by constant rate infusion 
(CRI) of 0.05 ml/kg/min for 4 hours was administered. 
Within one hour of finishing the initial bolus and starting 
the lipid CRI, the cat’s breathing patter underwent a 
change with the excursions becoming deeper and heart 
rate increased to 144 beats/min. The rectal temperature 
increased to 38.1°C. Patient mental state improved 
although it appeared still severely disoriented. Pupils were 
normal in size, pupillary light reflex and menace reaction 
were present bilaterally. The lipid CRI was continued for 
further 3 hours. During that time, the cat became 
appropriately responsive during handling. It started to 
stand and walk with mild ataxia. Respiratory and heart 
rate normalized. Upon discontinuation of the lipid 
emulsion, intravenously fluid therapy was continued with 
Ringer lactate solution at a rate of 5 ml/kg/hr. On day 2, 
the cat showed complete resolution of neurologic signs. 
Heart and respiratory rate were in the reference range. The 
cat developed hyperthermia (rectal temperature, 40°C). 
On day 3, rectal temperature decreased up to 39.5°C 
without drug administration. The cat began eating and 
drinking itself. On day 4, rectal temperature was normal. 
Intravenously fluid therapy was gradually decreased up to 
the interruption. On day 5, rectal temperature, heart and 
respiratory rate were within reference interval. 
Neurological exam revealed no abnormalities. The cat 
was discharged from the hospital. The owner reported that 
the cat was completely normal during a telephone follow-





Little information is available about baclofen 
intoxication in cats. Five cats, of which only two survived, 
were reported in a retrospective study (Khorzad et al., 
2012). Recently, the use of ILE was described in a cat 
with acute baclofen intoxication (Edwards et al., 2014). 
The ILE is a solution of medium and long chain 
triglycerides traditionally used to deliver essential fatty 
acids as part of parenteral nutrition. In the last decade, 
there has been increasing evidence supporting its use to 
attenuate or reverse clinical manifestations of lipophilic 
toxins in people and domestic animals (Fernandez et al., 
2011). In dogs, ILE was used for management of 
ivermectin, moxidectin, diltiazem, loperamide, ibuprofen 
and baclofen intoxications. In cats, ILE was described in 
lidocaine, permethrin and ivermectin toxicosis (Kidwell et 
al., 2014; Long et al., 2017; Robben and Dijkman, 2017). 
The exact mechanism of ILE remains incompletely 
elucidated. The lipid sink theory proposes that the 
administration of ILE creates a lipid partition within the 
plasma that sequesters lipophilic drugs, drawing them 
away from target tissues and eliminating them with 
endogenous fat particles. The ILE is also thought to 
increase the amount of free fatty acids available to the 
myocardium for energy production. Other theorized 
mechanisms include a positive inotropic effect secondary 
to increased calcium concentration within the cells, 
inhibition of sodium channels and cytoprotection 
(Fernandez et al., 2011; Robben and Dijkman, 2017).  
The cat of this case ingested about 1.6 mg/kg of 
baclofen. Currently, there is no established toxic dose in 
domestic animals. The ingested dose of baclofen is known 
in 3 cats: 1.7 mg/kg, 10 mg/kg and 14.7 mg/kg, 
respectively. The cat that received the higher dose died 
and the survival status of the cat receiving the lower dose 
is not known (Khorzad et al., 2012). The cat ingested 10 
mg/kg survived (Edwards et al., 2014). In dogs, clinical 
signs are reported following to ingestion of doses from 0.7 
mg/kg to 61 mg/kg. Death was reported at dose as low as 
2.3 mg/kg. Given the wide range of described toxic doses 
and that 92% of baclofen poisonings result in the 
development of clinical signs, all ingestions of this drug 
should be considered clinically important (Khorzad et al., 
2012). Cats show ataxia, CNS depression, agitation, 
vomiting, diarrhoea, hypertension, bradycardia, 
vocalization, miosis, mydriasis, drowsiness and lethargy, 
tachypnea, respiratory arrest (Khorzad et al., 2012; 
Edwards et al., 2014). In the cat of this report clinical 
signs due to depression of the CNS were predominant. 
Lipid emulsion therapy started 2 hours after the admission 
to the hospital. The cat received a bolus of 2 ml/kg in 15 
minutes following by a CRI of 0.05 ml/kg/min over 4 
hours. The total amount of administered ILE was 42 ml. 
This dose is lower than that used in the previously 
reported cat with baclofen toxicosis (Edwards et al., 
2014). It was chosen to avoid fluid overload. In veterinary 
medicine, there is no established recommended dose for 
ILE in the treatment of lipophilic drug poisonings and it is 
often extrapolated from human data (Fernandez et al., 
2011). However, in all cases, including the present case, 
the lipid infusion was continued until a clinical response 
was noted. Cessation of ILE therapy should be undertaken 
with caution as recurrence of clinical signs has been 
reported (Edwards et al., 2014).  
In both people and companion animals, ILE is 
considered relatively safe. A single study evaluating toxic 
effects in a murine model found that the lethal dose 50 
was 67.7±10.7 ml/kg, which is significantly higher than 
the doses advocated for use in drug toxicosis (Kaplan and 
Whelan, 2012). Persistent lipemia and suspected corneal 
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lipidosis following ILE therapy were described in one cat 
with permethrin toxicosis (Seitz and Burkitt-Creedon, 
2016). The cat of this report tolerated ILE administration 
well. The fever origin and its relationship with ILE 
administration remained unknown. Neither phlebitis nor 
clinical or laboratory evidence of inflammation or 
infection was found. Fever was described as side effect in 
people treated with ILE as component of parenteral 
nutrition (Kaplan and Whelan, 2012).    
 
Conclusions: This report supports the use of ILE as 
adjunctive therapy in the treatment of baclofen toxicosis 
in cats. In circumstances where clinical signs are difficult 
to control with conventional therapies the use of ILE, 
which is relatively inexpensive, safe and accessible, 
appears justified.  
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